This event will bring together leading experts to explore the structure, latest advancements, persistent challenges, and future directions in the healthcare sector, with a specific focus on the pharmaceutical industry in the United States. Discussions will cover drug development costs, pricing strategies, regulatory impacts, policy and the balance between innovation and affordability.